Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SMN1 Antikörper

Dieses Anti-SMN1-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von SMN1 in WB und IP. Geeignet für Human.
Produktnummer ABIN6253498

Kurzübersicht für SMN1 Antikörper (ABIN6253498)

Target

Alle SMN1 Antikörper anzeigen
SMN1 (Survival of Motor Neuron 1, Telomeric (SMN1))

Reaktivität

  • 59
  • 33
  • 16
  • 6
  • 6
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 65
  • 9
Maus

Klonalität

  • 56
  • 18
Monoklonal

Konjugat

  • 36
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser SMN1 Antikörper ist unkonjugiert

Applikation

  • 54
  • 27
  • 14
  • 13
  • 13
  • 11
  • 8
  • 8
  • 7
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB), Immunoprecipitation (IP)

Klon

7B10
  • Verwendungszweck

    anti-Survival Motor Neuron Protein (human), mAb (7B10)

    Produktmerkmale

    Monoclonal Antibody. Recognizes a sequence of up to 9 amino acids in the N-terminal domain of human SMN. Isotype: Mouse IgG1. Clone: 7B10. Applications: IP, WB. Liquid. In PBS. The SMN complex plays an essential role in spliceosomal snRNP assembly in the cytoplasm and is required for pre-mRNA splicing in the nucleus. It may also play a role in the metabolism of snoRNPs. It is expressed in a wide variety of tissues, including high levels in brain, kidney and liver, moderate levels in skeletal and cardiac muscle and low levels in fibroblasts and lymphocytes. Mutations in SMN cause spinal muscular atrophy 1 (SMA1). Spinal muscular atrophy is a group of neuromuscular disorders characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. The antibody was used extensively to purify and characterize the macromolecular SMN complex from cultured human cells. The antibody binds with high affinity and specificity to its epitope, which comprises a sequence of up to 9 amino acids in the N-terminal part of human SMN. It allows the native elution of bound antigen with an excess of the cognate peptide. Via addition of the 7B10 epitope (TagIt epitope) to other proteins this purification strategy can also be exploited for purification of these fusion proteins and RNA-protein complexes from cells lacking this epitope on endogenous proteins, such as cells derived from C. elegans and Drosophila.

    Aufreinigung

    Protein A/G purified.

    Immunogen

    Recombinant human full-length survival motor neuron protein (SMN).

    Isotyp

    IgG1
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    Lot specific

    Buffer

    Liquid. In PBS.

    Handhabung

    Avoid freeze/thaw cycles.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Short Term Storage: +4°C

    Long Term Storage: -20°C

    Use & Stability: Stable for at least 1 year after receipt when stored at -20°C.

  • Target

    SMN1 (Survival of Motor Neuron 1, Telomeric (SMN1))

    Andere Bezeichnung

    Survival Motor Neuron Protein

    Hintergrund

    Alternate Names/Synonyms: SMN, Gemin-1, Component of Gems 1, BCD541

    Product Description: The SMN complex plays an essential role in spliceosomal snRNP assembly in the cytoplasm and is required for pre-mRNA splicing in the nucleus. It may also play a role in the metabolism of snoRNPs. It is expressed in a wide variety of tissues, including high levels in brain, kidney and liver, moderate levels in skeletal and cardiac muscle and low levels in fibroblasts and lymphocytes. Mutations in SMN cause spinal muscular atrophy 1 (SMA1). Spinal muscular atrophy is a group of neuromuscular disorders characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. The antibody was used extensively to purify and characterize the macromolecular SMN complex from cultured human cells. The antibody binds with high affinity and specificity to its epitope, which comprises a sequence of up to 9 amino acids in the N-terminal part of human SMN. It allows the native elution of bound antigen with an excess of the cognate peptide. Via addition of the 7B10 epitope (TagIt epitope) to other proteins this purification strategy can also be exploited for purification of these fusion proteins and RNA-protein complexes from cells lacking this epitope on endogenous proteins, such as cells derived from C. elegans and Drosophila.

    UniProt

    Q16637

    Pathways

    Ribonucleoprotein Complex Subunit Organization
Sie sind hier:
Chat with us!